SVA Insider Trading

Insider Ownership Percentage: 12.98%
Insider Buying (Last 12 Months): C$92,771.00
Insider Selling (Last 12 Months): C$223,200.00

Sernova Insider Trading History Chart

This chart shows the insider buying and selling history at Sernova by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Sernova Share Price & Price History

Current Price: C$0.25
Price Change: Price Decrease of -0.01 (-3.92%)
As of 09/16/2024 03:54 PM ET

This chart shows the closing price history over time for SVA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Sernova Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/13/2024Steven SanghaDirectorBuy22,600C$0.26C$5,876.00
8/27/2024Steven SanghaDirectorSell930,000C$0.24C$223,200.00
8/15/2024Steven SanghaDirectorBuy100,000C$0.23C$23,000.00
8/6/2024Steven SanghaDirectorBuy100,000C$0.24C$24,000.00
7/30/2024Steven SanghaDirectorBuy35,000C$0.28C$9,625.00
7/22/2024Steven SanghaDirectorBuy11,000C$0.28C$3,080.00
7/19/2024Steven SanghaDirectorBuy51,000C$0.29C$14,790.00
7/15/2024Steven SanghaDirectorBuy40,000C$0.31C$12,400.00
6/17/2022Frank HollerDirectorBuy50,000C$1.29C$64,500.00583,333
See Full Table

SEC Filings (Institutional Ownership Changes) for Sernova (TSE:SVA)

0.05% of Sernova stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Sernova logo
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.
Read More on Sernova

Today's Range

Now: C$0.25
Low: C$0.25
High: C$0.27

50 Day Range

MA: C$0.27
Low: C$0.21
High: C$0.33

52 Week Range

Now: C$0.25
Low: C$0.20
High: C$0.83

Volume

159,389 shs

Average Volume

184,289 shs

Market Capitalization

C$79.48 million

P/E Ratio

N/A

Dividend Yield

7.86%

Beta

1.38

Who are the company insiders with the largest holdings of Sernova?

Sernova's top insider investors include:
  1. Steven Sangha (Director)
Learn More about top insider investors at Sernova.